Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Physician practice leaders ‘alarmed’ by skyrocketing cost of prior authorization policies

A new analysis estimates that the price tag for radiologists and other specialties to manually generate a prior authorization increased 60% between 2018 and 2019. 

Thumbnail

Conservative groups launch ad blitz to stop surprise medical billing proposal opposed by radiologists

The “Coalition Against Rate-Setting,” launched in January, wants to bury bipartisan legislation proposed to address this issue. 

Thumbnail

Pharma industry lobbying hit $29M in 2019

The pharmaceutical industry upped its lobbying efforts in 2019, with a record-high of $29 million spent lobbying Congress.

Thumbnail

Civica Rx, Blue Cross Blue Shield tackle high-cost generic medications with new subsidiary

Civica Rx and the Blue Cross Blue Shield Association and 18 of its health plans have teamed up to create a new subsidiary that will target low-cost generic drugs.

Thumbnail

How US could fall behind China in AI development

The United States is still viewed as the world’s leader in researching and developing AI solutions—but could that reputation be at stake?

Thumbnail

$13.3B of healthcare administration could be automated

One-third of healthcare administrative spending could be automated and save $13.3 billion, according to a report by CAQH.

Thumbnail

Centene, WellCare $17.3B merger clears regulatory requirements

Centene has passed all regulatory hurdles to seal the deal on a merger with WellCare Health Plans worth $17.3 billion.

Thumbnail

Amazon ramps up trademarks for pharmacy business

Amazon is signaling it may soon sell prescription drugs in the U.K., Canada and Australia after the company moved to trademark “Amazon Pharmacy” in those countries at the start of 2020, CNBC reported.